Company Search:
Advanced Search
Sponsored Links
Mitsubishi Tanabe Pharma Corp Company Snapshot
Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other companies in this sector in Japan: Kyowa Hakko Kirin Company Limited (2017 sales of 353.38 billion Japanese Yen [US$3.28 billion] of which 78% was Pharmaceutical Business), Shionogi & Co Ltd (338.89 billion Japanese Yen [US$3.15 billion] of which 100% was Pharmaceuticals), and Chugai Pharmaceutical Co Ltd (534.20 billion Japanese Yen [US$4.96 billion] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended March of 2017, sales at Mitsubishi Tanabe Pharma Corp were ¥423.98 billion (US$3.94 billion). This is a decrease of 1.8% versus 2016, when the company's sales were ¥431.70 billion. The sales level in 2017 was fairly close to the level five years ago: in 2012, Mitsubishi Tanabe Pharma Corp had sales of ¥407.16 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mitsubishi Tanabe Pharma Corp
  Stock Performance Chart for Mitsubishi Tanabe Pharma Corp
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 2,092.00
(Figures in Japanese Yen)
1 Week 0.0%   13 Weeks -4.3%  
4 Weeks -6.7%   52 Weeks -6.2%  
Mitsubishi Tanabe Pharma Corp Key Data:
  Ticker: 4508 Country: Japan
  Exchanges: TYO OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 423,977,000,000
(Year Ending Jan 2018).
Employees: 7,280
  Currency: Japanese Yen Market Cap: 1,173,143,624,212
  Fiscal Yr Ends: March Shares Outstanding: 560,776,111
  Share Type: Common Closely Held Shares: 323,238,416
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.